It may therefore be a valuable addition to treatment protocols specifically for patients with similar dynamic gating abnormalities in a high-frequency firing state (e.g. status epilepticus) and may warrant further detailed study in whole organism models of such SCN1A mutations. This evidence concerns the gene SCN1A and status epilepticus.